Olusegun Michael Otunuga is an Assistant Professor in the Department of Mathematics at the College of Science and Mathematics and the Department of Population Health Science: Division of Biostatistics and Data Science at Augusta University. He holds a Ph.D. in Pure & Applied Mathematics from the University of South Florida and has been actively contributing to interdisciplinary research in stochastic modeling, epidemiology, biostatistics, and financial mathematics. Ph.D., Pure & Applied Mathematics, University of South Florida, 2014 M.S., Mathematics, Marshall University, 2009 B.Sc., Mathematics, Federal University of Agriculture, Nigeria, 2006 Dr. Otunuga's research focuses on the development and analysis of stochastic models to understand complex systems in biology, medicine, and economics. His work spans tumor growth dynamics under environmental stress, multi-strain epidemic modeling (including HIV, TB, measles, and COVID-19), vaccine breakthrough infections, and financial time series forecasting. He employs advanced techniques such as stochastic differential equations, parameter estimation, and first-passage-time analysis. The recent publications highlight a strong trend in applying mathematical rigor to public health challenges, particularly in modeling infectious disease spread with stochastic realism. His work bridges theoretical mathematics with practical applications in biostatistics and data science, often involving real-world data from U.S. states and global health contexts. The integration of time-varying parameters and random perturbations enhances model accuracy and predictive power. Scientific Awards: Excellence in Research Award, College of Science and Mathematics, Augusta University, 2024 Dr. Otunuga actively mentors students and serves as a faculty advisor for Pi Mu Epsilon and Goldwater Scholarship candidates. He has not received mention of specific grants in the provided text, but his sustained publication record and patent suggest active research funding. He contributes extensively to academic service through multiple committees at the department, college, and university levels, and has served as a reviewer for scholarly journals. He is involved in research teams and workshops such as the POPUPS Workshop at Augusta University, where he leads training on biostatistics and data analysis using R. His collaborative work includes joint research with the Ladde research group, culminating in a patented method for dynamic process modeling.
جستوجوی استاد و پژوهشگر
استاد راهنما، استاد دانشگاه یا پژوهشگر مناسب برای مسیر پژوهشیتان را پیدا کنید و با او ارتباط بگیرید.
نمایش ۶۱-۷۵ از ۱٬۱۶۴ استاد راهنما
اطلاعات این پروفایلها از صفحات عمومی دانشگاهها جمعآوری شده و ممکن است بهروز نباشد.
Kayvan Bozorgmehr is a Professor in Public Health at the Faculty of Health Sciences, Bielefeld University , specializing in Social Epidemiology, Health Services Research, and Forced Migration . He leads the Section Health Equity Studies & Migration and directs the Research Lab for Population Medicine . Medical Doctor (Frankfurt) Dr. med. (Charité Berlin) MSc. Public Health (Umeå University) Habilitation in Health Services Research and Social Epidemiology (Heidelberg University) His research focuses on structural, social and economic determinants of refugee health , with emphasis on health equity, migration policy, and health system resilience . He has led major projects like RESPOND , PRICARE , and NEXUS , funded by BMBF, BMG, DFG, and EU. Recent publications analyze refugee health system resilience , social isolation impacts , COVID-19 disparities , and housing environment effects on migrant mental health. His work appears in The Lancet , BMJ Global Health , and SSM - Population Health . Scientific Awards: Stephan-Weiland Prize (German Society for Epidemiology, 2015) Ferenc-Boyan Young Investigator Award (European Public Health Association, 2016) Bozorgmehr serves as consultant to WHO Europe , IOM , and Robert Koch Institute , and co-chairs the German Alliance for Global Health Research . His lab develops privacy-preserving data linkage methods for refugee health studies.
Rachel Tannerمشاهده پروفایل
دانشیار
Rachel Tanner is an Associate Professor and Lecturer in Human Sciences at Wadham College, University of Oxford, with additional appointments as Research Fellow at Wolfson College and Access Officer for the Institute of Human Sciences. Her research focuses on tuberculosis vaccine development through analysis of immune correlates, particularly the humoral response to BCG vaccination and development of functional in vitro assays. Education MA in Biological Sciences, University of Oxford DPhil in Clinical Medicine, University of Oxford Her work addresses critical gaps in TB vaccine development by: Identifying humoral immune correlates of protection Developing in vitro mycobacterial growth inhibition assays (MGIA) to reduce animal use Investigating controlled human infection models Exploring non-specific effects of BCG vaccination Advancing bovine TB vaccine research She leads initiatives aligning with the 3Rs principles for animal research. Notable scientific awards include: TBVI Young Scientist Award (2017) CTVD Early Career Scientist Award (2018) 'Women of the Future' Award for Science (2019) Current research projects involve: Comparative analysis of BCG and MTBVAC vaccines Route-specific antibody functionality Development of novel TB vaccine candidates Standardisation of functional immune assays She contributes to scientific governance through roles on: British Society for Immunology Vaccine Affinity Group Acid Fast Club committee Oxford University Animal Care and Ethical Review 3Rs subcommittee Scientific Reports Editorial Board
- Public Health
- Malaria
- Chronic Diseases
- +۵ مورد دیگر
Wakgari A. Deressa is a renowned researcher with 9 years of publications and 21 total works, achieving 2,840 citations and an H-index of 29 . His work focuses on public health challenges in sub-Saharan Africa, particularly malaria prevention , health disparities , and chronic disease management . Supported by major funders like the Medical Research Council and NIH, he has published extensively in journals such as BMC Pregnancy and Childbirth and Malaria Journal . Active research across 12 institutions in Ethiopia, Kenya, and Sudan Co-authorship network spans 31 institutions globally Research Themes : His work addresses critical issues including healthcare access inequities , environmental health impacts , and preventive strategies for infectious diseases like tuberculosis and malaria. He investigates socio-demographic barriers to interventions such as insecticide-treated bed net usage and PMTCT services for HIV. Publication Trends : Recent studies focus on border malaria transmission in Ethiopia (2023) and socioeconomic disparities in Kenyan malaria prevention. Earlier works examine maternal health engagement (2020), mosquito sampling methods (2017), and substance use patterns in medical students (2011). Grant Support : His research is funded by prestigious organizations including the Medical Research Council , National Institutes of Health , and National Research Foundation . Collaborative projects involve institutions like Addis Ababa University and the Faculty of Computers and Information at Cairo University.
Jeffery S. Cox is a Professor in the Department of Molecular & Cell Biology at the University of California, Berkeley, holding the C.H. Li Chair of Biochemistry and Molecular Endocrinology. His research focuses on understanding the symbiotic relationship between Mycobacterium tuberculosis and its human host to develop novel therapeutic strategies for tuberculosis (TB) eradication. Research Expertise: Host-pathogen interactions, innate immunity, host-directed therapy, genetics, proteomics, and transcriptional profiling. Professor Cox's lab investigates how macrophages intrinsically control bacterial viability and shape immune responses, challenging conventional wisdom by demonstrating that macrophages can discriminate virulent from non-virulent M. tuberculosis through advanced techniques like CRISPR genetics and mass spectrometry-based proteomics. This work aims to harness macrophage pathways for therapeutic intervention. The lab's research highlights unconventional strategies targeting innate immune responses, particularly macrophage activation, as a promising approach to combat TB infection. This aligns with their focus on breaking the co-evolutionary ties between M. tuberculosis and humans.
Orlando Stefanoمشاهده پروفایل
استادیار
- Public Health
- Global Health
- HIV/AIDS Research
- +۵ مورد دیگر
Orlando Stefano is an Assistant Professor at the Department of Hygiene and Public Health, University of Rome Tor Vergata. He specializes in global health, HIV/AIDS research, and epidemiology, with a focus on sub-Saharan Africa. His work includes studies on vaccine strategies, healthcare system transformation, and the impact of pandemics on healthcare delivery. He currently teaches courses on global health prevention and the evolving challenges in health systems. Research interests encompass maternal and child health, particularly in HIV-exposed infants, as well as aging populations and frailty assessment. He has contributed to initiatives like the DREAM program, addressing comorbidities in HIV patients and evaluating virological outcomes in Mozambique. His studies on gender dynamics in healthcare decision-making and the effects of public health measures on infection rates highlight his interdisciplinary approach. Key themes in his publications include vaccine efficacy in resource-limited settings, tuberculosis diagnosis during the pandemic, and the role of community-based care systems. His work frequently integrates clinical data with public health policy analysis, emphasizing actionable solutions for global health challenges. Stefano has advised on interventions to improve male partner involvement in maternal health programs in Malawi and has explored the economic impacts of healthcare resource allocation in sub-Saharan Africa. His research also addresses the socioeconomic implications of HIV treatment programs and the management of noncommunicable diseases in aging populations.
Christopher M. Sassetti is a Professor in the Department of Microbiology at the University of Massachusetts Chan Medical School (UMass Chan Medical School) and T.H. Chan School of Medicine. His research focuses on the pathogenesis of Mycobacterium tuberculosis, specifically understanding how the bacterium adapts to host environments, acquires nutrients, regulates its cell wall physiology, and survives antibiotic treatment. He completed his BS in Biology at Santa Clara University and his PhD in Immunology at the University of California, San Francisco. Dr. Sassetti leads the Sassetti Lab, which employs genetic, biochemical, and systems biology approaches to study tuberculosis. His work has identified critical metabolic pathways and survival mechanisms in M. tuberculosis, including cholesterol utilization and cell wall synthesis regulation. He holds additional academic roles in the Morningside Graduate School of Biomedical Sciences, including the Immunology and Microbiology Program, MD/PhD Program, and Postbaccalaureate Research Education Program. Recent research highlights include studies on host immune responses to tuberculosis, antibiotic efficacy under infection conditions, and the role of genetic interactions in pathogen survival. His lab has discovered that host fatty acid metabolism and autophagy pathways play key roles in restricting bacterial growth. Dr. Sassetti has been recognized as a Damon Runyon Foundation Scholar and has contributed to high-impact publications in Immunity , Science , and Cell . Current projects include understanding nutrient acquisition in vivo, phosphosignaling regulation of cell wall synthesis, and metabolic mechanisms driving antibiotic tolerance. Collaborative efforts with institutions like the Morningside Graduate School and global networks drive translational research toward novel tuberculosis therapies and vaccines.
- Microbiology
- Vaccinology
- Bacterial Genetics
- +۴ مورد دیگر
Professor Simon Cutting is a distinguished faculty member in the Department of Biological Sciences at Royal Holloway, University of London, where he leads research in microbiology, bacterial genetics, and vaccine development. His work focuses on Bacillus species (particularly B. subtilis), gut microbiome interactions, and developing spore-based vaccines against infectious diseases including Helicobacter pylori, Clostridioides difficile, tuberculosis, and malaria. Professor Cutting's research interests center on microbial pathogenesis, probiotic development, and novel vaccine platforms. His work spans from fundamental bacterial genetics to translational applications, with particular emphasis on how spore-forming bacteria can be engineered for therapeutic purposes. His COLORSSPORE project explores microbial carotenoids, while his INNOVAC initiative develops recombinant vaccines for TB and malaria. The DELPHE Initiative focuses on international higher education partnerships, reflecting his commitment to global scientific collaboration. Analysis of Professor Cutting's recent publications reveals a strong focus on gut microbiome interactions, particularly how Bacillus species can modulate inflammatory responses and combat pathogenic bacteria like Clostridioides difficile and Helicobacter pylori. His work bridges basic microbiology with clinical applications, developing novel therapeutic approaches that leverage bacterial spores as delivery vehicles for vaccines and immunomodulatory compounds. Professor Cutting has secured significant research funding from major organizations including the Medical Research Council, European Commission, and DEFRA/BBSRC. His projects include "Helicobacter pylori in Vietnam: Prevalence, AMR and Vaccination" (2020-2023), "Control of Clostridium Difficile: An Emerging Threat to the European Livestock Industry" (2014-2017), and "Oral Vaccination against Clostridium difficile Infection" (2013-2016). His laboratory at the Centre for Biomedical Sciences investigates Bacillus subtilis genetics and its applications in human health, with particular focus on how bacterial spores can be engineered as vaccine vectors and probiotic therapeutics. Professor Cutting has supervised multiple graduate students and maintains active collaborations with researchers in Vietnam and across Europe.
Brendan Dyettمشاهده پروفایل
پژوهشگر ارشد
Brendan Dyett is a Research Fellow at RMIT University, supported by an Australian Research Council Discovery Early Career Award. His research focuses on nanoscale dynamics at interfaces using microscopy and scattering techniques. He investigates lipid nanoparticle-cell interactions, non-wetting thin films, and surface nanobubbles/droplets, with applications in overcoming biological barriers for therapeutic delivery. He is affiliated with RMIT’s Research & Innovation Portfolio and teaches courses such as CHEM1015 (Environmental Chemical Issues) and ONPS2186 (Applied Science Project). His research interests span colloid and surface chemistry, nanomedicine, and modeling/simulation. He contributes to UN Sustainable Development Goals 3 (Good Health) and 10 (Reduced Inequalities). Recent projects include developing lipid nanocarriers for mRNA delivery and antimicrobial peptide encapsulation. Awards: Australian Research Council Discovery Early Career Award Grants: ARC-funded research on lipid nanoparticle mechanistic studies Collaborations: Industry projects and media inquiries welcomed His work bridges fundamental materials science with biomedical applications, emphasizing nanostructured systems for drug delivery and disease treatment.
Diego Silvaمشاهده پروفایل
مدرس ارشد
Dr. Diego Silva is a Senior Lecturer in Bioethics at Sydney Health Ethics and the Sydney School of Public Health, University of Sydney. His work bridges public health ethics, political theory, and infectious disease management, with a focus on tuberculosis, antimicrobial resistance, and pandemic preparedness. He combines qualitative methods with conceptual analysis to address ethical challenges in health security. Education: BA & MA in Philosophy (University of Toronto), PhD in Public Health (University of Toronto) Research Interests Public Health Ethics Infectious Diseases Health Security Complexity and Systems Thinking Microbiome Research Recent Article Trends 2024 SSH Consortium grant on immuno-engineering infrastructure 2024-2026 CIHR-funded TB genomics project 2024 ZiF grant on territoriality ethics Peer-reviewed publications in journals like BMJ Global Health, Monash Bioethics Review, and PloS One Scientific Awards Mark S. Ehrenreich Prize (2016) Supervision Accepts higher-degree research students in Public Health Ethics, Global Health Ethics, and Health Policy Associations International Association of Bioethics International Union Against Tuberculosis and Lung Disease Dr. Silva teaches BETH5101 - Moral Theory and BETH5104 - Bioethics, Law, and Policy, while maintaining active collaborations with the World Health Organization and Public Health Agency of Canada.
Julia L. Finkelstein, MS, MPH, ScD, is Associate Professor of Epidemiology and Nutrition in the Division of Nutritional Sciences at Cornell University’s College of Human Ecology and concurrently Associate Professor of Epidemiology in the Division of Epidemiology, Department of Population Health Sciences at Weill Cornell Medical College. She is the Follett Sesquicentennial Faculty Fellow , Director of the Maternal and Child Nutrition Program , and co-Director of the Joan Klein Jacobs Center for Precision Nutrition and Health , the Cochrane Center , and the WHO Collaborating Centre at Cornell. She also holds an adjunct Associate Professor appointment at St. John’s Research Institute, Bengaluru, India . Education Bachelor of Science – McGill University, Montréal, Canada Master of Public Health – Brown University, USA Master of Science – Harvard University (Epidemiology and Nutrition) Doctor of Science – Harvard University (Epidemiology and Nutrition) Research Focus Dr. Finkelstein is an epidemiologist whose laboratory centers on one-carbon metabolism and its role in women’s health across the lifespan—from preconception through pregnancy and postpartum. She designs and conducts large-scale randomized clinical trials, cohort studies, and surveillance programs in resource-limited settings in India, Sub-Saharan Africa, Latin America, and the United States . Her work integrates precision nutrition, mobile point-of-care diagnostics, and AI-driven analytics to improve maternal, neonatal, and child health outcomes. Scientific Awards & Honors NIH Technology Accelerator Challenge Prize – Innovative Global Health Diagnostics SUNY Chancellor Award for Scholarship & Creative Activities International Life Sciences Institute (ILSI) Award – Leadership in Nutrition Chair, Federation of American Societies for Experimental Biology (FASEB) One-Carbon Metabolism Research Interest Group (recently elected) Grants & Leadership Roles Dr. Finkelstein is Program Director of an NIH-funded training program on maternal and child nutrition and leads the Clinical Core of the NIH-funded PORTENT Center (Point-of-Care Diagnostics for Nutrition, Infection, and Cancer) within the NIH POCTRN network. She is a Global Public Voices Fellow (2021–22) through Cornell’s Einaudi Center, advocating for social and health equity in vulnerable populations. Laboratory & Teams The Finkelstein Laboratory at Cornell focuses on mechanistic and translational research in one-carbon metabolism, leveraging state-of-the-art biomarker assays, body-composition analyses, and microbiome profiling to develop and test precision nutrition interventions for women and children globally.
Matthias Rieger is a Full Professor at the Erasmus School of Health Policy & Management, Global Health department at Erasmus University Rotterdam. His academic profile demonstrates a strong commitment to interdisciplinary research at the intersection of economics and health policy. Professor Rieger's research focuses on Development Economics, Health Economics, and Behavioral/Experimental Economics. His work employs rigorous methodological approaches including synthetic control methods, field experiments, and survey experiments to address pressing global health challenges. His fingerprint analysis reveals particular expertise in corruption economics, public service delivery, and team teaching methodologies. His publication record shows consistent output with 43 research contributions including 39 articles, 3 working papers, and 1 book chapter. His most recent work spans diverse geographical contexts including Indonesia, Mexico, Cambodia, Brazil, and South Africa, demonstrating a strong international research presence. 12 citations for food choice experiments with children in Indonesia 37 citations for trade in foods research in Mexico 14 citations for self-help groups research in Cambodia 27 citations for particle pollution and cognition studies in Brazil Professor Rieger has supervised 5 research projects and maintains active collaborations across multiple countries, with particular emphasis on Global South contexts where health and economic challenges intersect. His research has been referenced in policy documents and shared widely through academic networks.
Dr. Thomas Manning is a Professor at Valdosta State University teaching Instrumental Analysis, Environmental Chemistry, Physical Chemistry, and marine-related courses. His research bridges pharmaceutical innovation and marine ecosystem restoration, with significant contributions to drug development for cancer, infectious diseases, and neurological disorders. Education: B.S. in Chemistry, College of Charleston M.S. in Chemistry, University of Florida Ph.D. in Chemistry, University of Florida His primary research focuses on metal-based drug complexes, yielding 20 pre-clinical candidates at the National Cancer Institute, a patented multidrug-resistant tuberculosis treatment, and novel COVID-19 therapies. Concurrently, he leads oyster and coral restoration projects applying chemical defense systems and nutrient substrates to marine rehabilitation. His work integrates medicinal chemistry with environmental science to address therapeutic and ecological challenges. Recent publications (2025-2016) reveal consistent themes: copper/iron complexes enhancing drug efficacy against cancer and infections (e.g., paclitaxel-copper crystals, isoniazid repurposing), inhalation therapies for tuberculosis/COVID-19, and microbial-nutrient systems for marine restoration. These span pharmaceutical chemistry, virology, and marine ecology, demonstrating translational applications from antiviral agents to coral reef rehabilitation. Dr. Manning mentors undergraduate researchers in his lab, producing patented drugs and pre-clinical candidates through National Cancer Institute collaborations. His marine restoration projects involve field implementation of microbial coatings and mineral substrates for oyster/coral rehabilitation, supported by university resources and interdisciplinary partnerships. Based in Bailey Science Building #3076, his research group leverages university facilities for drug synthesis and marine ecosystem studies, maintaining active projects in pharmaceutical development and coastal habitat restoration through undergraduate-driven innovation.
- Tuberculosis
- Diagnostics
- Epidemiology
- +۳ مورد دیگر
Madhukar Pai, MD, PhD is a Senior Scientist at the Research Institute of the McGill University Health Centre (RI-MUHC) , based at the Montreal General Hospital site, and a Professor in the Department of Epidemiology, Biostatistics and Occupational Health at McGill University’s Faculty of Medicine and Health Sciences . He also holds an appointment in the Division of Respiratory Medicine, Department of Medicine, MUHC . He leads research within the Infectious Diseases and Immunity in Global Health Program and the Centre for Outcomes Research and Evaluation (CORE) . Education: MD – Medical degree (institution and year not specified in text) PhD – Doctoral degree (field and institution not specified in text) Research Interests: Professor Pai’s research revolves around tuberculosis (TB) , a disease causing 10 million new cases and 1.4 million deaths annually. His work integrates epidemiology , diagnostics evaluation , implementation science , and global health policy to accelerate TB control. A major strand involves rigorous evaluation of novel rapid molecular diagnostics compared to conventional tests, assessing accuracy, cost-effectiveness, and readiness for national policy adoption. He employs standardised (mystery) patients to measure quality of TB care in private and public sectors across India , South Africa , Indonesia , and Nigeria . The COVID-19 pandemic has added a new dimension, examining disruptions to TB services and leveraging lessons for resilient health systems. His overarching goal is translational epidemiology —ensuring that scientific advances rapidly translate into policies and practices that save lives. Publication Trends: Between 2022 and 2025, Professor Pai has published prolifically on TB diagnostics , care cascades , COVID-19 impacts , private sector engagement , antimicrobial resistance , and decolonizing global health . His articles frequently appear in The Lancet , BMJ Global Health , PLoS Medicine , and Nature Reviews Disease Primers , reflecting a commitment to high-impact, policy-relevant science. Methodological contributions include systematic reviews, meta-analyses, standardised patient studies, and qualitative policy analyses. Scientific Awards & Recognition: (No specific named awards detailed in the provided text) Funding & Grants: Professor Pai’s research is supported by competitive international grants focused on TB diagnostics implementation, health systems strengthening, and pandemic preparedness. While exact grant titles and amounts are not listed, his extensive publication record attests to sustained funding from agencies invested in global health research. Labs & Teams: He leads a multidisciplinary team within the Centre for Outcomes Research and Evaluation (CORE) and the Infectious Diseases and Immunity in Global Health Program at RI-MUHC. Collaborations span McGill University, the McGill International TB Centre, and numerous partners in high-burden countries.
- HIV/AIDS
- Cancer
- Implementation Science
- +۵ مورد دیگر
Raul U. Hernandez-Ramirez is a Research Scientist in Biostatistics at the Center for Methods in Implementation and Prevention Science (CMIPS) at the Yale School of Public Health. He serves as Director of the Dissemination and Implementation Science Methods (DISM) Core at the Center for Interdisciplinary Research on AIDS (CIRA) and is an Affiliated Faculty member at the Yale Institute for Global Health. His work bridges biostatistics, implementation science, and global health research with a focus on practical applications for public health improvement. Dr. Hernandez-Ramirez earned his PhD in Public Health (Chronic Disease Epidemiology) from Yale University in 2018, following an MPhil in the same field in 2016. During his doctoral studies, he conducted research as a predoctoral visiting fellow at the National Cancer Institute (NCI). He further enhanced his expertise through specialized training programs including the Training Institute for Dissemination and Implementation Research in Cancer (TIDIRC) and the Multilevel Intervention Training Institute (MLTI) from NCI, as well as training in optimization of multicomponent interventions using the Multiphase Optimization Strategy (MOST). His research primarily focuses on HIV/AIDS, cancer, and implementation science. He develops and applies causal inference methods for evaluating HIV prevention interventions and methods to account for exposure uncertainty in environmental health studies. His work spans multiple settings including New Haven, other locations in the United States, and low- and middle-income countries, particularly Mexico. He is particularly interested in adapting and developing interventions to increase the uptake of evidence-based practices for HIV and cancer prevention and care, including follow-up care for abnormal cervical cancer screens. He is a member of the Yale Cancer Center (YCC) and the Yale Institute for Global Health (YIGH). Analysis of Dr. Hernandez-Ramirez's recent publications reveals a strong focus on gastric cancer epidemiology through the Stomach cancer Pooling (StoP) Project, examining dietary factors and their relationship to cancer risk. His work prominently features implementation science methodologies applied to HIV prevention and cancer screening programs, particularly in Mexican and other international settings. His research combines rigorous biostatistical methods with practical applications in global health contexts, with significant contributions to causal inference methods and network-randomized trial analysis. Provides expertise, consultations, and technical assistance on implementation science through CIRA's DISM core Contributes to projects in Ending the HIV Epidemic (EHE) priority areas through the CIRA-affiliated IS hub R3EDI Collaborates on research projects in New Haven, other US settings, and low- and middle-income countries including Mexico Offers seminars and trainings on research methods, design, and analysis to CIRA affiliates Dr. Hernandez-Ramirez previously gained substantial research experience in nutrition, environmental health, and cancer at the National Institute of Public Health of Mexico, where he worked as a researcher and instructor and served as project coordinator, data manager, and main statistician for a multistate study. He holds an MSc in Epidemiology and a BSc in Nutrition, establishing a strong foundation for his current work at the intersection of nutritional epidemiology and implementation science.
فقط ۷۵۰ نتیجه اول نمایش داده میشود. برای رسیدن به نتایج دقیقتر، جستوجو را با فیلترها محدودتر کنید.